DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Fockens P, Mulder CJ, Tytgat GN. et al
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group.
Eur J Gastroenterol Hepatol 1995; 7: 1025-1030
We do not assume any responsibility for the contents of the web pages of other providers.